Literature DB >> 11728700

Uncertainties in model-based outcome predictions for treatment planning.

J O Deasy1, K S Chao, J Markman.   

Abstract

PURPOSE: Model-based treatment-plan-specific outcome predictions (such as normal tissue complication probability [NTCP] or the relative reduction in salivary function) are typically presented without reference to underlying uncertainties. We provide a method to assess the reliability of treatment-plan-specific dose-volume outcome model predictions. METHODS AND MATERIALS: A practical method is proposed for evaluating model prediction based on the original input data together with bootstrap-based estimates of parameter uncertainties. The general framework is applicable to continuous variable predictions (e.g., prediction of long-term salivary function) and dichotomous variable predictions (e.g., tumor control probability [TCP] or NTCP). Using bootstrap resampling, a histogram of the likelihood of alternative parameter values is generated. For a given patient and treatment plan we generate a histogram of alternative model results by computing the model predicted outcome for each parameter set in the bootstrap list. Residual uncertainty ("noise") is accounted for by adding a random component to the computed outcome values. The residual noise distribution is estimated from the original fit between model predictions and patient data.
RESULTS: The method is demonstrated using a continuous-endpoint model to predict long-term salivary function for head-and-neck cancer patients. Histograms represent the probabilities for the level of posttreatment salivary function based on the input clinical data, the salivary function model, and the three-dimensional dose distribution. For some patients there is significant uncertainty in the prediction of xerostomia, whereas for other patients the predictions are expected to be more reliable. In contrast, TCP and NTCP endpoints are dichotomous, and parameter uncertainties should be folded directly into the estimated probabilities, thereby improving the accuracy of the estimates. Using bootstrap parameter estimates, competing treatment plans can be ranked based on the probability that one plan is superior to another. Thus, reliability of plan ranking could also be assessed.
CONCLUSIONS: A comprehensive framework for incorporating uncertainties into treatment-plan-specific outcome predictions is described. Uncertainty histograms for continuous variable endpoint models provide a straightforward method for visual review of the reliability of outcome predictions for each treatment plan.

Entities:  

Mesh:

Year:  2001        PMID: 11728700     DOI: 10.1016/s0360-3016(01)02659-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Radiotherapy dose-volume effects on salivary gland function.

Authors:  Joseph O Deasy; Vitali Moiseenko; Lawrence Marks; K S Clifford Chao; Jiho Nam; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.

Authors:  Maria Thor; Adepitan A Owosho; Haley D Clark; Jung Hun Oh; Nadeem Riaz; Allan Hovan; Jillian Tsai; Steven D Thomas; Sae Hee K Yom; Jonn S Wu; Joseph M Huryn; Vitali Moiseenko; Nancy Y Lee; Cherry L Estilo; Joseph O Deasy
Journal:  Radiother Oncol       Date:  2016-11-24       Impact factor: 6.280

3.  Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.

Authors:  Nitin Ohri; Maria Werner-Wasik; Inga S Grills; José Belderbos; Andrew Hope; Di Yan; Larry L Kestin; Matthias Guckenberger; Jan-Jakob Sonke; Jean-Pierre Bissonnette; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-01       Impact factor: 7.038

4.  Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.

Authors:  E K Uzel; S Karaçam; O Eliçin; O Uzel
Journal:  Strahlenther Onkol       Date:  2013-06-09       Impact factor: 3.621

Review 5.  Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modelling.

Authors:  Sujith Baliga; Madhur K Garg; Jana Fox; Shalom Kalnicki; Patrick A Lasala; Mary R Welch; Wolfgang A Tomé; Nitin Ohri
Journal:  Br J Radiol       Date:  2016-12-12       Impact factor: 3.039

6.  Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study.

Authors:  Nalee Kim; Jason Chia-Hsien Cheng; Nitin Ohri; Wen-Yen Huang; Tomoki Kimura; Zhao Chong Zeng; Victor Ho Fun Lee; Chul Seung Kay; Jinsil Seong
Journal:  J Hepatocell Carcinoma       Date:  2022-08-06

7.  Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History.

Authors:  Rafi Kabarriti; N Patrik Brodin; Maxim I Maron; Wolfgang A Tomé; Balazs Halmos; Chandan Guha; Shalom Kalnicki; Madhur K Garg; Nitin Ohri
Journal:  Adv Radiat Oncol       Date:  2020-05-20

8.  Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?

Authors:  Laura Cella; Giuseppe Palma; Joseph O Deasy; Jung Hun Oh; Raffaele Liuzzi; Vittoria D'Avino; Manuel Conson; Novella Pugliese; Marco Picardi; Marco Salvatore; Roberto Pacelli
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

9.  A new plan quality index for dose painting radiotherapy.

Authors:  Yang-Kyun Park; Soyeon Park; Hong-Gyun Wu; Siyong Kim
Journal:  J Appl Clin Med Phys       Date:  2014-07-08       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.